Objective The objective of this study is to characterise concurrent use of benzodiazepine
receptor modulators and opioids among prescription opioid users in Alberta in 2017. Design A …

Importance Machine learning approaches can assist opioid stewardship by identifying high-risk
opioid prescribing for potential interventions. Objective To develop a machine learning …

BACKGROUND Antiplatelet therapy is recommended as part of a strategy to reduce the risk
of cardiovascular events in patients with type 2 diabetes. However, compliance with these …

Purpose Reducing initial exposure of “opioid naïve” patients to opioids is a public health
priority. Identifying opioid naïve patients is difficult, as numerous definitions are used. The …

Objective To determine if inappropriate tapering/discontinuation of opioids to Alberta patients
occurred from mid-2013–2020, as unintended consequences of prescribing guidelines, …

… Ntumy, Vincent Ganu, Miriam Sam, and Jennifer Norman; analysis and interpretation of data:
Fizza S. Gilani, Hongmei Yang, Gena M. Burch, Charles A. Peloquin, and Awewura Kwara. …

Background: There is increasing concern over the use of benzodiazepine receptor agonists
(BZRAs). The objective of this study was to describe BZRA dispensations in the province of …

Results Overall, 372,870 individuals received 2,463,585 BZRA dispensations in 2015 (10%
of Alberta population). The majority of users were female (63%), 28% were 65 years of age …

Purpose: Reducing initial exposure of “opioid naïve” patients to opioids is a public health
priority. Identifying opioid naïve patients is difficult, as numerous definitions are used. The …

Background: Statin-associated muscle symptoms (SAMS) are the most common cause of
statin discontinuation. Randomized clinical trials of proprotein convertase subtilisin kexin 9 (…